Anthera Pharmaceuticals, Inc. (ANTH)

Anthera Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Revenue	-	0.15	3.19	-	-
Revenue Growth (YoY)	-	-95.45%	-	-	-
Cost of Revenue	28.49	46.25	30.86	21.84	21.68
Gross Profit	-28.49	-46.11	-27.68	-21.84	-21.68
Selling, General & Admin	7.94	11.07	7.57	6.62	6.56
Operating Expenses	7.94	11.07	7.57	6.62	6.56
Operating Income	-36.43	-57.18	-35.24	-28.46	-28.25
Interest Expense	-	-	-	-1.05	-2.6
Currency Exchange Gain (Loss)	-	-	-	-	-0.02
Other Non Operating Income (Expenses)	10.16	1.65	0.02	-0.1	-
EBT Excluding Unusual Items	-26.27	-55.52	-35.22	-29.6	-30.86
Other Unusual Items	-0.6	-	-	-	-
Pretax Income	-26.87	-55.52	-35.22	-29.6	-30.86
Net Income	-26.87	-55.52	-35.22	-29.6	-30.86
Preferred Dividends & Other Adjustments	2.5	10.91	-	-	-
Net Income to Common	-29.38	-66.44	-35.22	-29.6	-30.86
Shares Outstanding (Basic)	10	5	4	3	2
Shares Outstanding (Diluted)	10	5	4	3	2
Shares Change (YoY)	99.05%	15.94%	63.62%	19.21%	152.82%
EPS (Basic)	-2.86	-12.87	-7.91	-10.88	-13.52
EPS (Diluted)	-2.86	-12.87	-7.91	-10.88	-13.52
Free Cash Flow	-36.9	-49.69	-30.99	-25.6	-31.93
Free Cash Flow Per Share	-3.59	-9.62	-6.96	-9.40	-13.98
Operating Margin	-	-39432.41%	-1106.53%	-	-
Profit Margin	-	-45818.62%	-1105.81%	-	-
Free Cash Flow Margin	-	-34265.52%	-972.90%	-	-
EBITDA	-36.15	-56.91	-34.96	-28.12	-27.89
D&A For EBITDA	0.28	0.27	0.29	0.34	0.35
EBIT	-36.43	-57.18	-35.24	-28.46	-28.25
Revenue as Reported	-	0.15	3.19	-	-

Updated May 15, 2018. Source: S&P Global Market Intelligence. Standard template. Financial Sources.